Suchergebnisse - "Guo, Yiqing"

PubPharm (82)

1

Label-free analysis of the β-hydroxybutyricacid drug on mitochondrial redox states repairment in type 2 diabetic mice by resonance raman scattering

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Wang, N. | Yang, A. | Tian, X. | +5

2

SNX17 Mediates Dendritic Spine Maturation via p140Cap

enthalten in: Molecular neurobiology | 2024

von Cui, Q. | Liang, S. | Li, H. | +9

3

The multifaceted roles of COL4A4 in lung adenocarcinoma : An integrated bioinformatics and experimental study

enthalten in: Computers in biology and medicine | 2024

von Zheng, T. | Zheng, Z. | Zhou, H. | +2

4

Metabolite profiling and identification of enzymes responsible for the metabolism of hirsutine, a major alkaloid from Uncaria rhynchophylla

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2023

von Guo, Y. | Lv, H. | Lv, J. | +1

5

Ca2+-induced release of IQSEC2/BRAG1 autoinhibition under physiological and pathological conditions

enthalten in: The Journal of cell biology | 2023

von Bai, G. | Li, H. | Qin, P. | +10

CommentIn: J Cell Biol. 2023 Dec 4;222(12):. - PMID 37938213

6

New treatments and trials for renal cell carcinoma : Latest updates from 2023 ASCO-GU Cancers Symposium

enthalten in: Asian journal of surgery | 2023

von Guo, Y. | Wu, R. | Ye, L. | +1

7

PRR7 could serve as a prognostic biomarker for prostate cancer patients

enthalten in: Asian journal of surgery | 2023

von Guo, Y. | Yu, Q. | Ke, M. | +1

8

Recombinant fibroblast growth factor 21 mutant and coding gene

enthalten in: Europäisches Patentamt | 2023

von YE SHENG | LIU SI | GUO YIQING | +4

9

Recombinant fibroblast growth factor 21 mutant and coding gene

enthalten in: Europäisches Patentamt | 2023

von YE SHENG | LIU SI | GUO YIQING | +4

10

SNX17 Mediates Dendritic Spine Maturation via p140Cap

enthalten in: Molecular neurobiology | 2023

von Cui, Q. | Liang, S. | Li, H. | +9

1
2
3
4
5
6
7
8
9
Nächster »
[9]